We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current FBLG market cap is 110.4M. The company's latest EPS is USD -0.5420 and P/E is -5.79.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -2.05M | -2.48M | -3.45M | -3.22M |
| Net Income | -2.19M | -12.29M | -8.46M | 898k |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -4.47M | -8.89M |
| Net Income | -5.12M | -19.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|
| USD ($) | USD ($) | |||
| Total Assets | 13.3M | 11.82M | 11.4M | 8.91M |
| Total Liabilities | 2.76M | 10.57M | 15.26M | 11.3M |
| Total Equity | 10.54M | 1.25M | -3.86M | -2.39M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Assets | 4.82M | 11.82M |
| Total Liabilities | 8.82M | 10.57M |
| Total Equity | -4M | 1.25M |
| Market Cap | 110.4M |
| Price to Earnings Ratio | -5.79 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 12.05 |
| Price to Book Ratio | 88.11 |
| Dividend Yield | - |
| Shares Outstanding | 35.16M |
| Average Volume (1 week) | 752.75k |
| Average Volume (1 Month) | 918.81k |
| 52 Week Change | -89.53% |
| 52 Week High | 55.00 |
| 52 Week Low | 1.0779 |
| Spread (Intraday) | 0.09 (2.87%) |
| Company Name | FibroBiologics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.fibrobiologics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
